Your search returned 5 results.

Results
	1.	Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis. [electronic resource] by Ramirez-Ardila, Diana Timmermans, A Mieke Helmijr, Jean A Martens, John W M Berns, Els M J J Jansen, Maurice P H M Publication details: Translational oncology Oct 2017 In: Translational oncology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome. [electronic resource] by Ramirez-Ardila, Diana E Ruigrok-Ritstier, Kirsten Helmijr, Jean C Look, Maxime P van Laere, Steven Dirix, Luc Berns, Els M J J Jansen, Maurice P H M Producer: 20171031 In: Molecular oncology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen. [electronic resource] by Ramirez-Ardila, Diana E Helmijr, Jean C Look, Maxime P Lurkin, Irene Ruigrok-Ritstier, Kirsten van Laere, Steven Dirix, Luc Sweep, Fred C Span, Paul N Linn, Sabine C Foekens, John A Sleijfer, Stefan Berns, Els M J J Jansen, Maurice P H M Producer: 20131023 In: Breast cancer research and treatment vol. 139 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen. [electronic resource] by Jansen, Maurice Phm Martens, John Wm Helmijr, Jean Ca Beaufort, Corine M van Marion, Ronald Krol, Niels Mg Monkhorst, Kim Trapman-Jansen, Anita Mac Meijer-van Gelder, Marion E Weerts, Marjolein Ja Ramirez-Ardila, Diana E Dubbink, Hendrikus Jan Foekens, John A Sleijfer, Stefan Berns, Els Mjj Producer: 20171229 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease. [electronic resource] by Jansen, Maurice P H M Sas, Leen Sieuwerts, Anieta M Van Cauwenberghe, Caroline Ramirez-Ardila, Diana Look, Maxime Ruigrok-Ritstier, Kirsten Finetti, Pascal Bertucci, François Timmermans, Mieke M van Deurzen, Carolien H M Martens, John W M Simon, Iris Roepman, Paul Linn, Sabine C van Dam, Peter Kok, Marleen Lardon, Filip Vermeulen, Peter B Foekens, John A Dirix, Luc Berns, Els M J J Van Laere, Steven Producer: 20160208 In: Molecular oncology vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)